Table 1. Baseline Patient Characteristics.
| Characteristic | Patients, No. (%) | |
|---|---|---|
| P2Y12i (n = 694) | DAPT (n = 693) | |
| Age, mean (SD), y | 62.8 (10.9) | 63.2 (10.5) |
| Sex | ||
| Women | 156 (22.5) | 176 (25.4) |
| Men | 538 (77.5) | 517 (74.6) |
| BMI, mean (SD) | 25.1 (3.2) | 25.0 (3.5) |
| Comorbidities | ||
| Hypertension | 393 (56.7) | 419 (60.5) |
| Dyslipidemia | 282 (40.7) | 310 (44.8) |
| Diabetes | 227 (32.8) | 243 (35.1) |
| Current smoker | 215 (31.0) | 189 (27.3) |
| Congestive heart failure | 7 (1.0) | 9 (1.3) |
| Chronic kidney disease | 23 (3.3) | 17 (2.5) |
| Previous PCI | 74 (10.7) | 102 (14.7) |
| Previous CABG | 13 (1.9) | 6 (0.9) |
| Previous myocardial infarction | 36 (5.2) | 40 (5.8) |
| Previous stroke | 27 (3.9) | 34 (4.9) |
| Clinical presentation | ||
| Chronic coronary syndrome | 181 (26.1) | 183 (26.4) |
| Acute coronary syndrome | 513 (73.9) | 510 (73.6) |
| P2Y12 inhibitor | ||
| Clopidogrel | 427 (61.5) | 440 (63.5) |
| Ticagrelor | 267 (38.5) | 253 (36.5) |
| Angiographic diagnosis | ||
| 1-Vessel disease | 402 (57.9) | 395 (57.0) |
| 2-Vessel disease | 188 (27.1) | 169 (24.4) |
| 3-Vessel disease | 104 (15.0) | 129 (18.6) |
| Total No. of treated lesions per patient, mean (SD) | 1.3 (0.6) | 1.3 (0.7) |
| Total No. of stents per patient, mean (SD) | 1.3 (0.6) | 1.3 (0.6) |
Abbreviations: BMI (calculated as weight in kilograms divided by height in meters squared); CABG, coronary artery bypass graft; DAPT, dual antiplatelet therapy; P2Y12i, P2Y12 inhibitor monotherapy; PCI, percutaneous coronary intervention.